Insider Trading & Ownership - Stephens Kristin

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Stephens Kristin
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-11-18
Sale
2024-11-20
5:00 pm
Syros Pharmaceuticals Inc.SYRSStephens Kristin
Chief Development Officer
36,133$0.22$7,9490
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-10-31
Exercise
2024-11-04
5:00 pm
N/A
N/A
Syros Pharmaceuticals Inc.SYRSStephens Kristin
Chief Development Officer
17,000$036,133
(Direct)
View
2024-10-31
Tax Withholding
2024-11-04
5:00 pm
N/A
N/A
Syros Pharmaceuticals Inc.SYRSStephens Kristin
Chief Development Officer
6,104$2.0936,133
(Direct)
View
2024-03-31
Exercise
2024-04-02
5:01 pm
N/A
N/A
Syros Pharmaceuticals Inc.SYRSStephens Kristin
Chief Development Officer
13,666$052,571
(Direct)
View
2024-04-01
Tax Withholding
2024-04-02
5:01 pm
N/A
N/A
Syros Pharmaceuticals Inc.SYRSStephens Kristin
Chief Development Officer
4,218$5.1252,571
(Direct)
View
2023-10-31
Exercise
2023-11-02
4:52 pm
N/A
N/A
Syros Pharmaceuticals Inc.SYRSStephens Kristin
Chief Development Officer
17,000$032,789
(Direct)
View
2023-11-01
Tax Withholding
2023-11-02
4:52 pm
N/A
N/A
Syros Pharmaceuticals Inc.SYRSStephens Kristin
Chief Development Officer
5,676$2.2232,789
(Direct)
View
2023-03-31
Exercise
2023-04-04
6:55 pm
N/A
N/A
Syros Pharmaceuticals Inc.SYRSStephens Kristin
Chief Development Officer
2,000$010,465
(Direct)
View
2023-04-03
Tax Withholding
2023-04-04
6:55 pm
N/A
N/A
Syros Pharmaceuticals Inc.SYRSStephens Kristin
Chief Development Officer
623$2.5810,465
(Direct)
View
2023-02-16
Option Award
2023-02-21
4:27 pm
N/A
N/A
Syros Pharmaceuticals Inc.SYRSStephens Kristin
Chief Development Officer
35,000$035,000
(Direct)
View
2022-10-06
Option Award
2022-10-11
4:39 pm
N/A
2032-10-05
Syros Pharmaceuticals Inc.SYRSStephens Kristin
Chief Development Officer
78,500$078,500
(Direct)
View
2022-04-01
Tax Withholding
2022-04-04
5:04 pm
N/A
N/A
Syros Pharmaceuticals Inc.SYRSStephens Kristin
Chief Development Officer
14,115$1.1230,885
(Direct)
View
2022-02-15
Option Award
2022-02-17
4:08 pm
N/A
2032-02-14
Syros Pharmaceuticals Inc.SYRSStephens Kristin
Chief Development Officer
380,000$0380,000
(Direct)
View

Ownership
2021-06-10
5:23 pm
N/A
N/A
Syros Pharmaceuticals Inc.SYRSStephens Kristin
Chief Development Officer
0$0407,832
(Direct)
View